Tower Research Capital LLC (Trc) Sorrento Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.17 - $1.19 $879 - $6,159	-5,176 Reduced 38.36%	8,316 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.74 - $1.83 $145,336 - $359,412	-196,400 Reduced 93.57%	13,492 $11,000
Q3 2022 Nov 10, 2022	BUY	$1.51 - $2.88 $203,415 - $387,970	134,712 Added 179.19%	209,892 $330,000
Q2 2022 Aug 15, 2022	SELL	$1.24 - $2.33 $60,742 - $114,137	-48,986 Reduced 39.45%	75,180 $151,000
Q1 2022 May 12, 2022	BUY	$2.0 - $4.9 $172,988 - $423,820	86,494 Added 229.6%	124,166 $289,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $218,884 - $340,330	-47,072 Reduced 55.55%	37,672 $175,000
Q3 2021 Nov 15, 2021	BUY	$7.41 - $10.99 $574,237 - $851,670	77,495 Added 1069.04%	84,744 $647,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $271,183 - $427,060	-42,706 Reduced 85.49%	7,249 $70,000
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $301,987 - $709,220	42,957 Added 613.85%	49,955 $413,000
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $1.55 Million - $3.22 Million	-269,716 Reduced 97.47%	6,998 $47,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $1.17 Million - $3.56 Million	189,302 Added 216.56%	276,714 $3.09 Million
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $151,222 - $590,905	87,412 New	87,412 $549,000
Q1 2020 May 15, 2020	SELL	$1.57 - $4.76 $152 - $461	-97 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$1.45 - $4.17 $20,014 - $57,558	-13,803 Reduced 99.3%	97 $0
Q3 2019 Nov 05, 2019	BUY	$2.05 - $2.69 $27,904 - $36,616	13,612 Added 4726.39%	13,900 $30,000
Q2 2019 Aug 13, 2019	BUY	$2.67 - $4.38 $501 - $823	188 Added 188.0%	288 $1,000
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $186 - $594	100 New	100 $0
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $41,705 - $87,975	-20,749 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$4.22 - $7.5 $87,560 - $155,617	20,749 New	20,749 $91,000
Q2 2018 Aug 15, 2018	SELL	$4.75 - $8.0 $475 - $800	-100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $450 - $994	100 New	100 $1,000
Q4 2017 Feb 09, 2018	SELL	$1.75 - $3.8 $5,026 - $10,913	-2,872 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.63 - $2.0 $4,681 - $5,744	2,872	2,872 $5,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account